Research News and Research

RSS
PD risk factors for potential clinical screening identified

PD risk factors for potential clinical screening identified

Arthritis patients prioritize lifestyle intervention research

Arthritis patients prioritize lifestyle intervention research

No return of body fat following liposuction

No return of body fat following liposuction

Talk smoothes the way to better understanding sick babies

Talk smoothes the way to better understanding sick babies

Enzalutamide extends castration-resistant prostate cancer survival

Enzalutamide extends castration-resistant prostate cancer survival

Evidence stacks up against bisphenol A

Evidence stacks up against bisphenol A

HPV genotype may alter chemoradiotherapy outcome

HPV genotype may alter chemoradiotherapy outcome

Live bacteria in more than 90% of middle ear effusions

Live bacteria in more than 90% of middle ear effusions

Three-step risk-screening method devised for Parkinson’s disease

Three-step risk-screening method devised for Parkinson’s disease

How's Medicare playing in the Florida Senate race

How's Medicare playing in the Florida Senate race

Controversial activities of pro-anorexic bloggers may have benefits

Controversial activities of pro-anorexic bloggers may have benefits

Mo. Senate candidate blasted for comments on rape

Mo. Senate candidate blasted for comments on rape

Injectable controlled-release capsules against gum disease

Injectable controlled-release capsules against gum disease

Agilent awarded patent for comparative genomic hybridization methods

Agilent awarded patent for comparative genomic hybridization methods

Appeals court dismisses challenge to doctor-owned hospital expansion limit in health law

Appeals court dismisses challenge to doctor-owned hospital expansion limit in health law

PPR proteins recognise RNA targets via easy-to-understand code

PPR proteins recognise RNA targets via easy-to-understand code

ARIAD initiates multi-center ponatinib Phase 1/2 clinical trial for CML in Japan

ARIAD initiates multi-center ponatinib Phase 1/2 clinical trial for CML in Japan

Political cartoon: 'A Little Extra Slice?'

Political cartoon: 'A Little Extra Slice?'

Anti-cancer regimens with multiple modes of action increase treatment effectiveness

Anti-cancer regimens with multiple modes of action increase treatment effectiveness

Ryan's positions on women's issues becomes campaign target

Ryan's positions on women's issues becomes campaign target

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.